SUCCESSFUL, HIGHLY PROFITABLE ($1+ MILLION), AND RAPIDLY GROWING (158% LAST
QTR) HEALTHCARE CONSOLIDATOR - SURGICARE - IS GOING TO START TRADING ON
AMEX LATER THIS WEEK - THIS CAN POTENTIALLY OPEN DOORS TO LARGER INVESTORS,
INSTITUTIONS AND VENTURE CAPITAL MARKETS -- READ ON!!!!
SurgiCare, Inc. (OTC BB: SXCR)
The popular book "How to be a Billionaire" lists industry consolidation as
one of the primary ways to increase wealth.
THIS IS EXACTLY what SurgiCare (OTC BB: SXCR) has been doing profitably
over the past few years. Last year, SXCR increased its revenues to $6.0
million, an impressive 43% rise over the previous year. But, more
importantly, it posted net earnings of $1.1 million - 18% of its total
revenues!
SurgiCare's growth strategy is powerful: it CONSOLIDATES the industry by
acquiring majority interests in Ambulatory Surgery Centers (ASCs).
LAST QUARTER THEIR REVENUES INCREASED - AGAIN - BY MORE THAN 157%!!!
The way SXCR consolidates the industry is unique: SXCR understands that
when physicians own and operate their centers, the centers tend to be
extremely profitable. That's why SXCR - after acquiring centers - lets the
centers' physicians continue playing managing roles in them. Traditionally,
physician-owned centers' profitability has decreased after an acquisition,
but not when it is structured "SurgiCare way".
ON THURSDAY, SXCR ANNOUNCED THAT IT WILL OPEN YET ANOTHER CENTER --
INCREASING THE NUMBER OF CENTERS BY 33%. AMEX LISTING WILL MAKE SXCR MORE
ACCESSIBLE TO NEW INVESTORS WHO WILL BE ABLE TO SEE THE PROGRESS THE
COMPANY HAS MADE.
NO WONDER THAT THE EXECUTIVES OF THE COMPANY HAVE RECENTLY FILED 144
PAPERWORK TO BUY MORE OF THEIR OWN STOCK. THIS IS PRETTY EXCEPTIONAL FOR
OTCBB COMPANIES.
When acquiring centers, SXCR also typically issues physicians shares or
other equity. This further boosts physicians' motivation. By integrating
the interests of its shareholders, management and physician-owners,
SurgiCare is reaching record revenues!!!
THE OPPORTUNITY: SurgiCare announced on Friday that the American Stock
Exchange has accepted its application to be listed on AMEX. The company
expects to be trading later this week under the symbol ERG.
As you probably know, most OTCBB stocks can never get the valuation they
deserve or the capital they need for several reasons. Most brokers can't
recommend 'penny stocks' to their clients, institutions don't typically
invest in OTCBB stocks and investment funds usually shy away from these
stocks as well.
The BILLION-dollar question is: if SXCR has already been able to reach $1+
million profits and a $3 per share valuation on the OTCBB, what will the
impact of its AMEX listing be?
Will Houston-based SurgiCare join the ranks of other similar healthcare
developers and consolidators, such as another Houston-based company, Dynacq
Intl. (Nasdaq: DYII), who's stock price has gone up by more than 500% in
the last year alone?
The AMEX listing is expected to enhance SurgiCare's ability to communicate
with a whole new group of investors who will now become familiar with
SXCR's continuous string of record profits and its unique acquisition and
consolidation strategy?
These types of moves usually also increase companies' abilities to reach
new funding sources, making capital potentially more available and
affordable for further growth.
Whether the AMEX listing will lead to ever faster growth or not, SXCR
continues full steam ahead with its strategy. In its most recent quarterly
SEC report, SXCR posted record revenues AGAIN, which grew by an astonishing
158% to over $3 million per quarter.
Those numbers don't even take into account the company's most recent news -
on Thursday SXCR announced that it will launch its latest multi-purpose
surgery center later this month. This will increase the number of company's
centers by another 33%.
SURGICARE: OTCBB: SXCR
Shares Outstanding 14M
Float 8M
Recent Price $3.00
Year Low/Hi $1.625-$6.00
Web site www.surgicareinc.com
Because these stocks offer considerable leverage at minimal cost, they
also have a high degree of risk. Please read our
Disclaimer.
